|
Published by: Espicom Healthcare Intelligence
Published: Jul. 4, 2008 - 204 Pages
Table of Contents
- FOREWORD
- OVERVIEW
- The Global Market for Biotechnology Pharmaceuticals
- Biotechnology Pharmaceuticals in the Global Market, 2007
- Leading Biopharmaceuticals by Revenue, 2007 (US$ million)
- Leading Biopharmaceuticals Ranked by US$ Revenue Growth, 2006/2007 (US$
- million)
- Global Pharmaceutical Sales by Region, 2008
- Estimated Global Biopharmaceutical Sales by Region, 2008
- Estimated South East Asian Biopharmaceutical Sales, 2008
- Estimated South East Asian Biopharmaceutical Sales, 2008
- Projected South East Asian Biopharmaceutical Sales, 2008-2013
- Case Study: India‟s Biopharmaceutical Market, 2002
- South East Asia - Pharmaceutical Market Data
- South East Asian Pharmaceutical Market, 2008-13 (US$ Millions)
- South East Asian Pharmaceutical Market Per Capita, 2008-13 (US$)*
- South East Asian Pharmaceutical Market AAGR, 2008-13 (%)
- South East Asia - Demographic Data
- South East Asian Population*, 2008-13 (Millions)
- South East Asian Population Growth*, 2008-13 (%)
- South East Asian Population*, Number Aged 65+, 2008-13 (Millions)
- South East Asian Population*, % Aged 65+, 2008-13
- South East Asia - Economic Data
- South East Asian GDP*, 2008-13 (US$ Billions)
- South East Asian GDP Per Capita*, 2008-13 (US$)
- South East Asian Real GDP Growth*, 2008-13 (%)
- South East Asia - Healthcare Expenditure
- South East Asian Health Expenditure*, 2008-13 (US$ Billions)
- South East Asian Health Expenditure Per Capita*, 2008-13 (US$)
- South East Asian Health Expenditure as % of GDP*, 2008-13
- South East Asia - Pharmaceutical Trade
- South East Asian Pharmaceutical Imports, 2001-06 (US$000s)
- South East Asian Pharmaceutical Exports, 2001-06 (US$000s)
- BIOTECHNOLOGY IN SOUTH EAST ASIA
- Selection of Biotechnology as a Key Strategic Area
- BIOPHARMACEUTICALS IN SOUTH EAST ASIA
- Biosimilars
- Rapidly growing markets
- Significant untapped demand
- Less competition from originators
- Greater acceptance from users
- Regulatory barriers are likely to be lower
- INDONESIA
- Biopharmaceutical Market
- Indonesia - Projected Biopharmaceutical Market 2008-2013 (US$ million)
- Pharmaceutical Market
- Summary of the Indonesian Pharmaceutical Market in 2008
- Projected Pharmaceutical Market, 2008-2013
- Market Environment
- Government Biotechnology Initiatives
- Biopharmaceutical Research Agencies
- Indonesian Institute of Sciences (Lembaga Ilmu Pengetahuan Indonesia - LIPI)
- Indonesian Biotechnology Consortium
- Galang Island
- Biopharmaceutical Manufacturing
- PT Bio Farma
- Partnerships
- Kalbe Farma Biotek
- Financials
- Kimia Farma
- Agreements
- LIPI
- Fraunhofer Institute
- Financials
- KOREA
- Biotechnology Market
- Korean Biotechnology Market 1994-2005
- Government Biotechnology Initiatives
- Korean Government Investment in Biotechnology R&D 1994-2006 (KRW billion) 50
- Korea‟s 2007-2016 Biotechnology Development Strategy
- Korea‟s 2006-2015 Biotechnology Development Strategy Targets (US$ billion)
- Investment
- Planned Investment in Korean Biotechnology 2007-2016
- Employment
- Biopharmaceutical Market
- Korea - Projected Biopharmaceutical Market 2008-2013 (US$ million)
- Pharmaceutical Market
- Summary of the Korean Pharmaceutical Market in 2008
- Projected Pharmaceutical Market, 2008-2013
- Market Environment
- Manufacturing & Research
- Bukwang Pharma
- Financials
- Bukwang Pharmaceutical - Key Financial Data 2004-2006* (KRW billion)
- Chemizon
- Agreements
- Korean Research Institute of Bioscience and Biotechnology (KRIBB)
- Crown Bioscience
- Takeda
- Array BioPharma
- Chong Kun Dang Bio
- Agreements
- Financials
- Choongwae Pharma
- CJ CheilJedang
- Agreements
- Neuralstem
- Daewoong Pharma
- Research
- Daewoong Pharma - Biopharmaceutical Pipeline
- Financials
- Daewoong Pharma - Key Financial Data 2005-2007* (KRW billion)
- Dong-A Pharma
- Biopharmaceutical Product Portfolio
- Dong-A Pharmaceutical - Biopharmaceutical Product Portfolio
- Dong-A Pharmaceutical Export Plan for Biopharmaceuticals
- Research
- Dong-A Pharmaceutical - R&D Pipeline
- DA-3031
- HB-110
- 2008 Plans
- Agreements
- Ukraine
- Financials
- Dong-A Pharmaceutical - Key Financial Data 2005-2007* (KRW billion)
- Dong-A Pharmaceutical - % of Revenues by Region, 2007 & 2012*
- Dong-A Pharmaceutical - Biopharmaceutical Revenues, 2007* (KRW billion)
- Green Cross
- Product Portfolio
- Blood Derivatives
- Vaccines
- R&D Pipeline
- Green Cross - R&D Pipeline
- Mogam Biotechnology Research Institute
- Financials
- Korea Stem Cell Bank
- Kuhnil Pharmaceutical Company
- Agreements
- YM BioSciences
- Viragen
- LG Life Sciences
- LG Life Sciences - Product Portfolio
- Financial Overview
- LG Life Sciences - Key Financial Data 2004-2006 (billion won)
- LG Life Sciences - Revenue by Segment, 2006
- Sewon Cellontech
- Agreements
- UCLB & RNOH
- SK Chemicals Life Science
- Yuhan Pharmaceuticals
- MALAYSIA
- Biopharmaceutical Market
- Malaysia - Projected Biopharmaceutical Market 2008-2013 (US$ million)
- Pharmaceutical Market
- Summary of the Malaysian Pharmaceutical Market in 2008
- Projected Pharmaceutical Market, 2008-2013
- Market Environment
- Government Biotechnology Initiatives
- Phase I -2006-2010 “Capacity Building”
- Phase II - 2011-2015 “Science to Business”
- Phase III - 2016-2020 “Global Presence”
- NBP Focus Areas
- Creation of BioNexus
- Tax Incentives
- Eighth National Plan 2001-2005
- Human Resource Development
- Research and Development
- Infrastructure and Facilities
- Regulatory Framework
- Public R&D Biotechnology Projects, 2001-2005
- Private Sector Participation
- Approved Biotechnology Manufacturing Projects, 2001-2005 (RM Million)
- Ninth National Plan 2006-2010
- Biotechnology Development
- Building a Malaysian Brand
- Regulatory Framework
- Financial Infrastructure
- Human Capital Development
- R&D and Technology Acquisition
- Institutional Support and Allocation
- Development Expenditure and Allocation for Biotechnology, 2001-2010 (RM
- million)
- Ministry of Science & Technology/BIOTEK
- Malaysian Biotechnology Corporation (BiotechCorp)
- Malaysian Bio-industry Organisation
- Incubators
- Manufacturing & Research
- Actis Biologics
- Actis Biologics - Pipeline
- Alpha Biologics
- Autoimmune Sdn Bhd
- BioFact Life Sdn Bhd
- Bio Molecular Industries Sdn Bhd
- Bioven
- EGF Cancer Vaccine
- Biovic Sdn Bhd
- CCM Duopharma Biotech
- Financials
- Inno Biologics
- Agreements
- GE Healthcare
- InQpharm Asia
- KL Biotech Manufacturing Sdn Bhd
- StemLife Berhad
- Stempeutics Research Malaysia Sdn Bhd
- Synamatix
- Agreements
- Universiti Malaysia Sabah Biotechnology Research Institute
- Emory University School of Medicine
- 454 Life Sciences
- Malaysian Genomics Resources Centre
- Vivantis Technologies Sdn Bhd (lab services)
- SINGAPORE
- Biotechnology Market Overview
- Investment
- Investment Commitments in Biomedical Manufacturing
- Biopharmaceutical Market
- Singapore - Projected Biopharmaceutical Market 2008-2013 (US$ million)
- Pharmaceutical Market
- Summary of the Singapore Pharmaceutical Market, 2008
- Market Projections, 2008-2013
- Market Environment
- Government Biotechnology Initiatives
- Biomedical Sciences Initiative
- Singapore Economic Development Board
- A*STAR
- Biomedical Research Council (BMRC)
- Biopolis
- Bio*One Capital
- Bio*One Capital Investment Funds
- Singapore Bio-Innovations (SBI)
- PharmBio Growth Fund/Life Sciences Investment Fund (PGF/LSI)
- Biomedical Sciences Investment Fund (BMSIF)
- BMS INC (Innovate „N‟ Create)
- Manufacturing & Research - Multinational Investments
- Genentech
- GlaxoSmithKline
- Lonza
- Schering-Plough
- Manufacturing & Research - Domestic
- 1st BASE
- A-Bio Pharma
- Agreements
- Artisan Pharma
- GSK Biologicals
- AMRI Singapore
- Agreements
- Achaogen
- Cystic Fibrosis Foundation
- Financials
- CellResearchCorp
- Chakra Biotech Sdn Bhd
- Chakragati Mouse
- Novel Compounds
- Agreements
- Tikvah Therapeutics
- University at Buffalo
- ES Cell International
- Agreements
- Curis
- Ortec International
- Quark Biotech
- Experimental Therapeutics Centre
- i-DNA Biotechnology
- Innogene Kalbiotech
- Innogene Kalbio - Product Portfolio
- Innogene Kalbiotech - Biopharmaceutical R&D Portfolio
- LYNK Biotechnologies
- MediLynk
- Financials
- Maccine
- Agreements
- MerLion
- Agreements
- Astellas Pharma
- Banyu Pharmaceutical
- National Cancer Institute
- National Parks Board of Singapore
- Novartis Institute for Tropical Diseases
- Financials
- Moleac
- S*BIO
- Research & Development
- Clinical Trials
- HDAC
- Kinase Programme
- S*BIO R&D Pipeline, 2008
- Agreements
- Genome Institute of Singapore
- Karolinska Institutet
- SciGen
- Product Portfolio
- Pipeline Products
- Financials
- SciGen Revenues by Geographic Breakdown, 2007
- SingVax
- Agreements
- Crucell
- OctoPlus
- TAIWAN
- Biotechnology Market Overview
- Current Status of Biotechnology Development in Taiwan - 2005
- Biopharmaceutical Market
- Taiwan - Projected Biopharmaceutical Market 2008-2013 (US$ million)
- Pharmaceutical Market
- Summary of the Taiwanese Pharmaceutical Market in 2008
- Projected Pharmaceutical Market, 2008-2013
- Market Environment
- Government Biotechnology Initiatives
- Promotion Plan for the Biotechnology Industry
- Bio-Tech Island Project
- Biotech and New Pharmaceutical Development Statute
- Investment
- Research
- Development Center for Biotechnology
- Manufacturing & Research
- Abnova
- Agreements
- Axela Biosensors
- AbGenomics
- AbGenomics - R&D Pipeline
- ADImmune
- Agreements
- Empax Pharma
- Agreements
- Life Spring BioTech
- Mycenax Biotech
- Mycenax - Project Pipeline
- NatureWise Biotech & Medicals
- Products
- R&D
- PhytoHealth
- ScinoPharm
- Financials
- Synmosa Biopharma
- TaiGen Biotechnology
- Agreements
- P&G Pharmaceuticals
- Academia Sinica
- Chang Gung Memorial Hospital
- BioXell SpA
- Arena Pharmaceuticals
- R&D
- TG-873870
- Nemonoxacin
- Financial Data
- TaiMed Biologics
- Taiwan Liposome
- Agreements
- SRI International
- Financials
- TTY Biopharm
- R&D
- Agreements
- TaiGen Biotechnology
- Taiwan Liposome
- YM BioSciences
- THAILAND
- Biotechnology Market Overview
- Biopharmaceutical Market
- Thailand - Projected Biopharmaceutical Market 2008-2013 (US$ million)
- Pharmaceutical Market
- Summary of the Thai Pharmaceutical Market, 2008
- Market Projections, 2008-2013
- Market Environment
- Compulsory Licensing
- Government Biotechnology Initiatives
- TCELS
- BIOTEC
- Manufacturing & Research
- Delphi Health Services
- Immunitor
- R&D Pipeline
- APPENDIX - BIBLIOGRAPHY
- APPENDIX - ACRONYMS
- APPENDIX - EXCHANGE RATES
AbstractThis detailed report analyses the market and research environments, assessing risk and identifying opportunity in Indonesia, Malaysia, Singapore, South Korea, Taiwan and Thailand.
Providing…
A thorough review of the burgeoning market for biopharmaceutical drugs in SE Asia
An examination of the markets in terms of investment and research opportunities
Market forecasts to 2013 for biopharmaceuticals
A review of over 65 local companies/ organisations developing biopharmaceutical products
Markets covered...
Indonesia
Malaysia
Singapore
South Korea
Taiwan
Thailand
Get Full Details About This Report >>
|
|
US: 800.298.5699
Int'l: +1.240.747.3093
|
|
|
|
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 300,000 market research reports,
company profiles and country profiles from over 700 research firms. Our reports will
provide you with the critical business and competitive intelligence you need for strategic planning and marketing
research. Coverage includes the US, UK, Europe, Asia and global markets.
© MarketResearch.com 2012
|
